1. Merck yielding 3.4% but is it sustainable? $MRK

  2. $LLY down today. Worth $44.46, down 47.37% from current share-price of $84.47. http://seekingalpha.com/article/3707566-eli-lilly-is-overvalued-too-costly-to-buy $JNJ $MRK $PFE $SNY $AGN $NVS $BMY

  3. Most bullish stocks on Twitter this month. $GOOGL $TGT $JCP $AMZN $NFLX $GILD $IBB $BBY $SCTY $FB $MRK $AGN $NKE https://www.tradefollowers.com/strength/twitter_strongest.jsp

  4. Get the best Drugs (& Pharma) stocks in our new scan. $PFE $GILD $KBIO $VRX $MRK & more https://itunes.apple.com/us/app/spark-fastest-daily-stock/id1041725710?mt=8


  6. $BMY $GILD $PFE $MRK $CELG $AZN $JUNO $SRNE $BLUE $KBIO $PPHM The biggest runner of 2016 is in my 11/15 SA article retail wins with cure!

  7. The sale process is at an early stage & could generate interest from both drug firms & private-equity co s, specified the sources. $MRK

  8. Merck ($MRK) is weighing a sale of its Allergopharma allergy unit that could fetch roughly $636M, reports Bloomberg, citing sources.

  9. http://seekingalpha.com/article/3707566-eli-lilly-is-overvalued-too-costly-to-buy $JNJ $MRK $PFE $SNY $LLY $AGN $NVS $BMY

  10. $MRK Max Pain = 54.00. Maturity = 12/04/2015. Previous close = 53.96. http://maximum-pain.com/options/max-pain?s=MRK&urk=MRK


  12. Dividend capture watchlist: Dividend yield+ High premiums. http://blog.optionsamurai.com/dividend-capture-watchlist-30-11-2015/ $MOS $VIAB $COH $GM $MRK $WMT $SU

  13. Stock Trends report - Major Drug Manufacturers, November 27, 2015 $PFE $MRK $JNJ stocktrends.com

  14. $MNKD Dr Mann, Announce CEO & New TS 4 Pain Trials B4 Next Friday??? $sny $goog $mnk $mrk $pfe

  15. $uvxy long $ubio long very good or $uvxy long tna long acting well $flml $mcur $vz $mrk

  16. How Can Roche Get 25% Boost In Revenues In 5 Years? http://www.trefis.com/stock/rhhby/articles/324389/how-can-roche-get-25-boost-in-revenues-in-5-years/2015-11-27 by Trefis Team $RHHBY $MRK $PFE

  17. Can Emerging Biosimilar Competition Cause 10% Downside To Roche s Valuation? http://www.trefis.com/stock/rhhby/articles/324371/can-emerging-biosimilar-competition-cause-10-downside-to-roches-valuation/2015-11-27 by Trefis Team $RHHBY $MRK $PFE

  18. What Drove 15% Growth in Roche s Earnings Between 2011-2014 Even Though Other Big P... http://www.trefis.com/stock/rhhby/articles/324092/what-drove-15-growth-in-roches-earnings-between-2011-2014-even-though-other-big-pharma-companies-suffered-a-decline/2015-11-27 by Trefis Team $RHHBY $MRK $PFE

  19. Can Roche Repeat 15% Earnings Growth It Saw Between 2011-2014 In The Next 3 Years? http://www.trefis.com/stock/rhhby/articles/324305/can-roche-repeat-15-earnings-growth-it-saw-between-2011-2014-in-the-next-3-years/2015-11-27 by Trefis Team $RHHBY $BMY $MRK

  20. Drugs vs Diagnostics: What s Roche s Revenues, Earnings and Valuation Breakdown? http://www.trefis.com/stock/rhhby/articles/324081/drugs-vs-diagnostics-whats-roches-revenues-earnings-and-valuation-breakdown/2015-11-27 by Trefis Team $RHHBY $BMY $MRK

  21. $LLY $JNJ $PFE $MRK $AGN Antares Pharma, A Classic Example Of Revenue Growth Being A Bad Thing https://brandpower.whotrades.com/blog/43091066873

  22. Recent #dividend increases: $VAL +10% (1.6% yield), $MRK +2% (3.4% yield). One is in our dividend growth portfolio: http://www.simplysafedividends.com/portfolios/long-term-dividend-growth/

  23. Long Cancer - Natures eco backlash zombie war on humans. Happy Thanksgiving $CGIX $PFE $MRK

  24. Our DCF shows Merck is available at a 19.0% discount $MRK:

  25. New trend detected on $MRK when price was 53,75 http://shark-finance.com?stc=MRK #TradingSystem #Randomwalk